H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. Census population 873,965. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed San Francisco clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a San Francisco storefront.
Biologic Solutions for Chronic Wounds in San Francisco, CA for clinics & physicians. Biologic solutions fo… Compliance support & pricing — contact Hawk Medical.
6.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. Population 873,965. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JE documentation are ready before the first application of biologic solutions chronic wounds.
National Biologic Solutions for Chronic Wounds notes (how the product actually works)6.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 873,965 residents will still mix those payers. CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. Adult arthritis here is 16.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for San Francisco.
CDC PLACES (2023, crude prevalence) estimates 9.7% of adults — 2.3 points below the U.S. 12% figure. Obesity is 17.5%; arthritis is 16.7%. That is place-level BRFSS modeling, not a clinic census and not a San Francisco trial.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
California is in CMS MAC JE, administered by Noridian Healthcare Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a California compliance risk.
Bring specialty, monthly wound volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 9.7% diabetes and 16.7% arthritis for San Francisco — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in San Francisco, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for San Francisco is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for San Francisco — 2.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in San Francisco. Useful for joint-program math; still needs a diagnosis and privileging.
No San Francisco storefront. Joe Bradley is an active practice owner. biologic solutions chronic wounds stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.